Sponsor or institution
Clinical trials and research at Myeloid Therapeutics
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Myeloid Therapeutics that are recruiting, at sites in 3 countries (most in Australia (4), South Korea (1), Taiwan (1)). By phase: Phase 1 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CR-402 treatment for refractory autoimmune disease | Phase 1/2 | Nedlands, Western Australia | Recruiting | Aug 21, 2026 |
| Testing MT-304, an mRNA lipid-nanoparticle anti-HER2 CAR therapy, in adults with advanced HER2-expressing solid tumors. | Phase 1 | Darlinghurst, New South Wales and 6 other locations | Recruiting | Jan 12, 2026 |
| Treatment of advanced liver cancer using MT-303 | Phase 1 | Sydney, New South Wales and 8 other locations | Recruiting | Jun 27, 2024 |
| Treatment of advanced epithelial tumors with MT-302 | Phase 1 | Darlinghurst, New South Wales and 5 other locations | Recruiting | Aug 1, 2023 |
All recruiting trials (4)
-
CR-402 treatment for refractory autoimmune disease
This study tests CRT-402, a CD19-targeted CAR-T therapy, in adults with active, treatment-resistant autoimmune diseases like SLE, systemic sclerosis, and inflammatory myopathy to see if it is safe and capable of helping control disease.
-
Testing MT-304, an mRNA lipid-nanoparticle anti-HER2 CAR therapy, in adults with advanced HER2-expressing solid tumors.
This will test MT-304, given alone or with nivolumab, in adults with advanced HER2-expressing solid tumors to find a safe dose and look for early signs of benefit.
-
Treatment of advanced liver cancer using MT-303
This study is testing a new treatment called MT-303 for adults with advanced liver cancer to see if it is safe and how well it works.
-
Treatment of advanced epithelial tumors with MT-302
This study is testing a new treatment called MT-302 to see if it's safe and effective for adults with advanced epithelial tumors.
Quick answers
How many clinical trials run by Myeloid Therapeutics are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (4 trials), South Korea (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.